Recipharm is a leading contract development and manufacturing organisation (CDMO) in the pharmaceutical industry, employing around 5000 employees
The awards, which recognise service excellence across pharmaceutical contract manufacturers, are organised by Life Science Leader and assess companies in six key areas, including quality, reliability, capabilities, expertise, compatibility and service.
Winners are identified through an Industry Standard Research (ISR) survey that obtains third party feedback from sponsor companies.
This year, more than 80 CMOs were measured against 26 performance indicators and ranked accordingly. As a result, Recipharm was selected as a winner in all six categories.
Thomas Eldered, CEO at Recipharm, said: “We’re delighted to have again been rewarded for our efforts as part of the CMO Leaderships Awards. These awards in particular allow us to gain an uncensored insight into how our customers feel we’re performing so it’s great to be recognised year on year.”
“At Recipharm, we’re dedicated to offering not only quality development and manufacturing services, but also ensuring our customers benefit from our expertise and wide-ranging capabilities, so to be recognised in all six categories this year is a fantastic achievement for us.”
This year’s award ceremony was held in New York yesterday. To find out more about the CMO Leadership Awards please click here.